174 related articles for article (PubMed ID: 27806083)
1. Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma.
Liu G; Dong C; Liu L
PLoS One; 2016; 11(11):e0165457. PubMed ID: 27806083
[TBL] [Abstract][Full Text] [Related]
2. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications.
Huang X; Yang C; Wang J; Sun T; Xiong H
Aging (Albany NY); 2020 Mar; 12(6):4970-4995. PubMed ID: 32201399
[TBL] [Abstract][Full Text] [Related]
4. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
5. iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models.
Ozdemir B; Abd-Almageed W; Roessler S; Wang XW
PLoS One; 2013; 8(11):e78624. PubMed ID: 24223834
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
[TBL] [Abstract][Full Text] [Related]
7. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
He H; Chen D; Cui S; Wu G; Piao H; Wang X; Ye P; Jin S
BMC Med Genomics; 2020 Aug; 13(1):118. PubMed ID: 32831081
[TBL] [Abstract][Full Text] [Related]
8. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
[TBL] [Abstract][Full Text] [Related]
9. Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
Song YZ; Li X; Li W; Wang Z; Li K; Xie FL; Zhang F
World J Gastroenterol; 2018 Jul; 24(28):3145-3154. PubMed ID: 30065560
[TBL] [Abstract][Full Text] [Related]
10. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
[TBL] [Abstract][Full Text] [Related]
12. Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.
Shen J; LeFave C; Sirosh I; Siegel AB; Tycko B; Santella RM
BMC Med Genomics; 2015 Jun; 8():28. PubMed ID: 26059414
[TBL] [Abstract][Full Text] [Related]
13. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
[TBL] [Abstract][Full Text] [Related]
14. Systemic transcriptome analysis of hepatocellular carcinoma.
Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
[TBL] [Abstract][Full Text] [Related]
16. Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
Wang Z; Zhang S
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212175
[TBL] [Abstract][Full Text] [Related]
17. Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis.
Ouyang X; Fan Q; Ling G; Shi Y; Hu F
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899915
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications.
Raja A; Haq F
J Cancer Res Clin Oncol; 2022 Jan; 148(1):15-29. PubMed ID: 34623518
[TBL] [Abstract][Full Text] [Related]
19. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.
Xu LX; He MH; Dai ZH; Yu J; Wang JG; Li XC; Jiang BB; Ke ZF; Su TH; Peng ZW; Guo Y; Chen ZB; Chen SL; Peng S; Kuang M
Ann Oncol; 2019 Jun; 30(6):990-997. PubMed ID: 30916311
[TBL] [Abstract][Full Text] [Related]
20. Computational analysis of TP53 vs. CTNNB1 mutations in hepatocellular carcinoma suggests distinct cancer subtypes with differential gene expression profiles and chromatin states.
Biterge Süt B
Comput Biol Chem; 2020 Dec; 89():107404. PubMed ID: 33096424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]